TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $132,713,000 | -13.5% | 8,102,119 | -11.1% | 2.41% | -5.2% |
| Q2 2021 | $153,414,000 | -47.8% | 9,115,521 | -43.4% | 2.54% | -49.1% |
| Q1 2021 | $294,063,000 | +5.9% | 16,104,222 | +5.5% | 4.98% | -21.8% |
| Q4 2020 | $277,741,000 | -7.3% | 15,260,512 | -9.1% | 6.37% | -32.3% |
| Q3 2020 | $299,508,000 | +3.1% | 16,788,589 | +3.7% | 9.40% | +17.4% |
| Q2 2020 | $290,382,000 | -4.1% | 16,195,310 | -18.8% | 8.00% | -2.8% |
| Q1 2020 | $302,947,000 | -49.8% | 19,956,999 | -34.7% | 8.24% | +55.9% |
| Q4 2019 | $603,397,000 | +27.8% | 30,582,721 | +11.4% | 5.28% | +6.4% |
| Q3 2019 | $472,034,000 | +0.9% | 27,443,846 | +3.8% | 4.97% | +17.1% |
| Q2 2019 | $467,826,000 | -12.0% | 26,430,828 | +1.2% | 4.24% | -10.7% |
| Q1 2019 | $531,915,000 | – | 26,112,660 | – | 4.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |